Luciferase Therapeutic Microcapsules for Gene Therapy

REFERENCES

• al-Hendy, A., Hortelano, G., Tannenbaum, G.S., Chang, P.L. (1995). Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts–an alternate approach to somatic gene therapy. Hum. Gene. Ther. 6:165–175.
   PubMedGoogle Scholar
• Ross, C.J., Bastedo, L., Maier, S.A., Sands, M.S., Chang, P.L. (2000). Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum. Gene. Ther. 11:2117–2127.
   PubMed Web of Science ®Google Scholar
• Hortelano, G., Al-Hendy, A., Ofosu, F.A., Chang, P.L. (1996). Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:5095–5103.
   PubMed Web of Science ®Google Scholar
• Cirone, P., Bourgeois, J.M., Austin, R.C., Chang, P.L. (2002). A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene. Ther. 13:1157–1166.
   PubMed Web of Science ®Google Scholar
• Lohr, M., Hoffmeyer, A., Kroger, J., Freund, M., Hain, J., Holle, A., Karle, P., Knofel, W.T., Liebe, S., Muller, P., Nizze, H., Renner, M., Saller, R.M., Wagner, T., Hauenstein, K., Gunzburg, W.H., Salmons, B. (2001). Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet. 357:1591–1592.
   PubMed Web of Science ®Google Scholar
• Shen, F., Poncet-Legrand, C., Somers, S., Slade, A., Yip, C., Duft, A.M., Winnik, F.M., Chang, P.L. (2003). Properties of a novel magnetized alginate for magnetic resonance imaging. Biotechnol. Bioeng. 83:282–292.
   PubMedGoogle Scholar
• Barnett, B.P., Arepally, A., Karmarkar, P.V., Qian, D., Gilson, W.D., Walczak, P., Howland, V., Lawler, L., Lauzon, C., Stuber, M., Kraitchman, D.L., Bulte, J.W. (2007). Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 13:986–991.
   PubMed Web of Science ®Google Scholar
• Ntziachristos, V., Yodh, A.G., Schnall, M., Chance, B. (2000). Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. U.S.A. 97:2767–2772.
   PubMed Web of Science ®Google Scholar
• Hawrysz, D.J., Sevick-Muraca, E.M. (2000). Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia. 2:388–417.
   PubMed Web of Science ®Google Scholar
• Tsien, R.Y. (1998). The green fluorescent protein. Annu. Rev. Biochem. 67:509–544.
   PubMed Web of Science ®Google Scholar
• Heim, R., Tsien, R.Y. (1996). Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol. 6:178–182.
   PubMed Web of Science ®Google Scholar
• Hastings, J.W. (1996). Chemistries and colors of bioluminescent reactions: a review. Gene. 173:5–11.
   PubMed Web of Science ®Google Scholar
• de Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R., Subramani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725–737.
   PubMed Web of Science ®Google Scholar
• Contag, C.H., Bachmann, M.H. (2002). Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4:235–260.
   PubMed Web of Science ®Google Scholar
• Rehemtulla, A., Stegman, L.D., Cardozo, S.J., Gupta, S., Hall, D.E., Contag, C.H., Ross, B.D. (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:491–495.
   PubMed Web of Science ®Google Scholar
• Lu, P.H., Negrin, R.S. (1994). A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J. Immunol. 153:1687–1696.
   PubMed Web of Science ®Google Scholar
• Edinger, M., Sweeney, T.J., Tucker, A.A., Olomu, A.B., Negrin, R.S., Contag, C.H. (1999). Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1:303–310.
   PubMedGoogle Scholar
• Sweeney, T.J., Mailander, V., Tucker, A.A., Olomu, A.B., Zhang, W., Cao, Y., Negrin, R.S., Contag, C.H. (1999). Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. U.S.A. 96:12044–12049.
   PubMed Web of Science ®Google Scholar
• Edinger, M., Cao, Y.A., Verneris, M.R., Bachmann, M.H., Contag, C.H., Negrin, R.S. (2003). Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood. 101:640–648.
   PubMed Web of Science ®Google Scholar
• Schmidt, E.V., Christoph, G., Zeller, R., Leder, P. (1990). The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10:4406–4411.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P., Jain, R.K. (2000). Angiogenesis in cancer and other diseases. Nature. 407:249–257.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, G., O’Kane, D.J., Szalay, A.A. (2001). A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP. Mol. Gen. Genet. 264:578–587.
   PubMedGoogle Scholar
• Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M.E., Iyer, M., Gambhir, S.S. (2002). Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl. Acad. Sci. U.S.A. 99:3105–3110.
   PubMedGoogle Scholar
• Cao, Y.A., Wagers, A.J., Beilhack, A., Dusich, J., Bachmann, M.H., Negrin, R.S., Weissman, I.L., Contag, C.H. (2004). Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. U.S.A. 101:221–226.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• Li, A.A., MacDonald, N.C., Chang, P.L. (2003). Effect of growth factors and extracellular matrix materials on the proliferation and differentiation of microencapsulated myoblasts. J. Biomater. Sci. Polym. Ed. 14:533–549.
   PubMed Web of Science ®Google Scholar
• Freshney, R. (1987). Culture of Animal Cells: A Manual of Basic Technique. Alan R. Liss Inc., New York, 117.
   Google Scholar
• Edinger, M., Cao, Y.A., Hornig, Y.S., Jenkins, D.E., Verneris, M.R., Bachmann, M.H., Negrin, R.S., Contag, C.H. (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur. J. Cancer. 38:2128–2136.
   PubMed Web of Science ®Google Scholar
• Rice, B.W., Cable, M.D., Nelson, M.B. (2001). In vivo imaging of light-emitting probes. J. Biomed. Opt. 6:432–440.
   PubMed Web of Science ®Google Scholar
• Cirone, P., Shen, F., Chang, P.L. (2005). A multiprong approach to cancer gene therapy by coencapsulated cells. Cancer. Gene. Ther. 12:369–380.
   PubMed Web of Science ®Google Scholar
• Shen, F., Li, A.A., Cornelius, R.M., Cirone, P., Childs, R.F., Brash, J.L., Chang, P.L. (2005). Biological properties of photocrosslinked alginate microcapsules. J. Biomed. Mater. Res. B. Appl. Biomater. 75:425–434.
   PubMedGoogle Scholar
• Krieg, A.M. (1999). Direct immunologic activities of CpG DNA and implications for gene therapy. J. Gene. Med. 1:56–63.
   PubMed Web of Science ®Google Scholar
• Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., Klinman, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:546–549.
   PubMed Web of Science ®Google Scholar
• Klinman, D.M., Yi, A.K., Beaucage, S.L., Conover, J., Krieg, A.M. (1996). CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93:2879–2883.
   PubMed Web of Science ®Google Scholar
• Sparwasser, T., Koch, E.S., Vabulas, R.M., Heeg, K., Lipford, G.B., Ellwart, J.W., Wagner, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045–2054.
   PubMed Web of Science ®Google Scholar
• Scheule, R.K., St George, J.A., Bagley, R.G., Marshall, J., Kaplan, J.M., Akita, G.Y., Wang, K.X., Lee, E.R., Harris, D.J., Jiang, C., Yew, N.S., Smith, A.E., Cheng, S.H. (1997). Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene. Ther. 8:689–707.
   PubMed Web of Science ®Google Scholar
• Yew, N.S., Zhao, H., Wu, I.H., Song, A., Tousignant, J.D., Przybylska, M., Cheng, S.H. (2000). Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1:255–262.
   PubMed Web of Science ®Google Scholar
• Yew, N.S., Zhao, H., Przybylska, M., Wu, I.H., Tousignant, J.D., Scheule, R.K., Cheng, S.H. (2002). CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. 5:731–738.
   PubMed Web of Science ®Google Scholar
• Zhao, H., Hemmi, H., Akira, S., Cheng, S.H., Scheule, R.K., Yew, N.S. (2004). Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. Mol. Ther. 9:241–248.
   PubMed Web of Science ®Google Scholar
• Hyde, S.C., Pringle, I.A., Abdullah, S., Lawton, A.E., Davies, L.A., Varathalingam, A., Nunez-Alonso, G., Green, A.M., Bazzani, R.P., Sumner-Jones, S.G., Chan, M., Li, H., Yew, N.S., Cheng, S.H., Boyd, A.C., Davies, J.C., Griesenbach, U., Porteous, D.J., Sheppard, D.N., Munkonge, F.M., Alton, E.W., Gill, D.R. (2008). CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 26:549–551.
   PubMed Web of Science ®Google Scholar
• Yew, N.S., Przybylska, M., Ziegler, R.J., Liu, D., Cheng, S.H. (2001). High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol. Ther. 4:75–82.
   PubMed Web of Science ®Google Scholar
• Cheng, D., Lo, C., Sefton, M.V. (2008). Effect of mouse VEGF(164) on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: Bioluminescence imaging. J. Biomed. Mater. Res A. 87:321–31.
   PubMedGoogle Scholar
• Surzyn, M., Symes, J., Medin, J.A., Sefton, M.V. (2008). IL-10 secretion increases signal persistence of HEMA-MMA-microencapsulated luciferase-modified CHO fibroblasts in mice. Tissue. Eng. Part A. 15:127–36.
   Google Scholar
• Loudovaris, T., Charlton, B., Hodgson, R.J., Mandel, T.E. (1992). Destruction of xenografts but not allografts within cell impermeable membranes. Transplant. Proc. 24:2291–2292.
   PubMedGoogle Scholar
• Bunger, C.M., Gerlach, C., Freier, T., Schmitz, K.P., Pilz, M., Werner, C., Jonas, L., Schareck, W., Hopt, U.T., de Vos, P. (2003). Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J. Biomed. Mater. Res. A. 67:1219–1227.
   PubMedGoogle Scholar
• Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423–434.
   PubMed Web of Science ®Google Scholar
• Li, M., Carpio, D.F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R.M., Beg, A.A. (2001). An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:7128–7135.
   PubMed Web of Science ®Google Scholar
• Schneider, B.L., Schwenter, F., Pralong, W.F., Aebischer, P. (2003). Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. Mol. Ther. 7:506–514.
   PubMed Web of Science ®Google Scholar